The Oncosearch | Oncotarget

HOXA11 hypermethylation is associated with progression of non-small cell lung cancer Research Paper

Jung-Ah Hwang, Bo Bin Lee, Yujin Kim, Seong-Eun Park, Kyun Heo, Seung-Hyun Hong, Young-Ho Kim, Joungho Han, Duk-Hwan Kim, Young Mog Shim, Yeon-Su Lee

Published Oct 28, 2013 · Vol. 4, No. 12 · pp. 2317-2325

Keywords: HOXA11, Hypermethylation, Non-small cell lung cancer, Progression, Migration

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper

John Wrangle, Wei Wang, Alexander Koch, Hariharan Easwaran, Helai P. Mohammad, Xiaoyu Pan, Frank Vendetti, Wim VanCriekinge, Tim DeMeyer, Zhengzong Du, Princy Parsana, Kristen Rodgers, Ray-Whay Yen, Cynthia A. Zahnow, Janis M. Taube, Julie R. Brahmer, Scott S. Tykodi, Keith Easton, Richard D. Carvajal, Peter A. Jones, Peter W. Laird, Daniel J. Weisenberger, Salina Tsai, Rosalyn A. Juergens, Suzanne L. Topalian, Charles M. Rudin, Malcolm V. Brock, Drew Pardoll, Stephen B. Baylin

Published Oct 25, 2013 · Vol. 4, No. 11 · pp. 2067-2079

The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis Research Paper

Cheryl McFarlane, Suzanne McFarlane, Ian Paul, Kenneth Arthur, Michael Scheaff, Keith Kerr, Michael Stevenson, Dean A Fennell, James A Johnston

Published Oct 3, 2013 · Vol. 4, No. 10 · pp. 1836-1843

Keywords: deubiquitination, USP17, NSCLC

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Laura Bonanno, Carlota Costa, Margarita Majem, Jose Javier Sanchez, Ana Gimenez-Capitan, Ignacio Rodriguez, Alain Vergenegre, Bartomeu Massuti, Adolfo Favaretto, Massimo Rugge, Cinta Pallares, Miquel Taron, Rafael Rosell

Published Jul 31, 2013 · Vol. 4, No. 10 · pp. 1572-1581

Keywords: BRCA1, 53BP1, DNA repair, predictive modeling, platinum

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer Research Paper

Alessia Noto, Claudia De Vitis, Giuseppe Roscilli, Luigi Fattore, Debora Malpicci, Emanuele Marra, Laura Luberto, Antonio D'Andrilli, Pierpaolo Coluccia, Maria Rosaria Giovagnoli, Nicola Normanno, Luigi Ruco, Luigi Aurisicchio, Rita Mancini, Gennaro Ciliberto

Published Jul 21, 2013 · Vol. 4, No. 8 · pp. 1253-1265

Keywords: Lung cancer, primary cultures, TKIs, ErbB3, monoclonal antibodies

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population Research Paper

Jennifer Wheler, Gerald Falchook, Apostolia M. Tsimberidou, David Hong, Aung Naing, Sarina Piha-Paul, Su S. Chen, John Heymach, Siqing Fu, Su S. Chen, Bettzy Stephen, Jansina Y. Fok, Filip Janku, Razelle Kurzrock

Published Jun 4, 2013 · Vol. 4, No. 5 · pp. 772-784

Keywords: EGFR mutation, EGFR wild-type, non-small cell lung cancer, phase I trials, resistance, squamous cell

Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer Research Paper

Gerald S. Falchook, Aung Naing, David S. Hong, Ralph G. Zinner, Siqing Fu, Sarina A. Piha-Paul, Apostolia M. Tsimberidou, Sonia K. Morgan-Linnell, Yunfang Jiang, Christel C. Bastida, Jennifer J. Wheler, Razelle Kurzrock

Published Jan 14, 2013 · Vol. 4, No. 1 · pp. 118-127

Notching up a new therapeutic strategy for Non-Small Cell Lung Carcinoma (NSCLC) Editorial

Antonio Maraver, Manuel Serrano

Published Sep 20, 2012 · Vol. 3, No. 9 · pp. 917-918

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review

Rodrigo Dienstmann, Pablo Martinez, Enriqueta Felip

Published Mar 23, 2011 · Vol. 2, No. 3 · pp. 165-177

Keywords: ALK, EGFR, KRAS, lung cancer, targeted therapy

Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Review

Joshua C. Curtin, Matthew V. Lorenzi

Published Oct 30, 2010 · Vol. 1, No. 7 · pp. 563-577

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

HOXA11 hypermethylation is associated with progression of non-small cell lung cancer Research Paper

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper

The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis Research Paper

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer Research Paper

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population Research Paper

Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer Research Paper

Notching up a new therapeutic strategy for Non-Small Cell Lung Carcinoma (NSCLC) Editorial

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review

Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Review

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

HOXA11 hypermethylation is associated with progression of non-small cell lung cancer Research Paper

Alterations of immune response of non-small cell lung cancer with Azacytidine Research Paper

The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis Research Paper

The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy Research Paper

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer Research Paper

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population Research Paper

Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer Research Paper

Notching up a new therapeutic strategy for Non-Small Cell Lung Carcinoma (NSCLC) Editorial

Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer Review

Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Review